|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.
|
|
3
|
Zhang Y, Zhang L, Zhang G, Li S, Duan J,
Cheng J, Ding G, Zhou C, Zhang J, Luo P, et al: Osteosarcoma
metastasis: Prospective role of ezrin. Tumour Biol. 35:5055–5059.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Farrill JS and Gordon N: Autophagy in
osteosarcoma. Adv Exp Med Biol. 804:147–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mussnich P, D'Angelo D, Leone V, Croce CM
and Fusco A: The High Mobility Group A proteins contribute to
thyroid cell transformation by regulating miR-603 and miR-10b
expression. Mol Oncol. 7:531–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ayaz L, Görür A, Yaroğlu HY, Ozcan C and
Tamer L: Differential expression of microRNAs in plasma of patients
with laryngeal squamous cell carcinoma: Potential early-detection
markers for laryngeal squamous cell carcinoma. J Cancer Res Clin
Oncol. 139:1499–1506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Angelo D, Palmieri D, Mussnich P, Roche
M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J and
Fusco A: Altered microRNA expression profile in human pituitary GH
adenomas: Down-regulation of miRNA targeting HMGA1, HMGA2, and
E2F1. J Clin Endocrinol Metab. 97:E1128–E1138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Li A, Hong SM, Hruban RH and Goggins
M: MicroRNA alterations of pancreatic intraepithelial neoplasias.
Clin Cancer Res. 18:981–992. 2012. View Article : Google Scholar :
|
|
9
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang FJ, Ding Y, Mao YY, Jing FY, Zhang
ZY, Jiang LF, Guo JF, Sun XJ, Jin MJ and Chen K: Associations
between hsa-miR-603 polymorphism, lifestyle-related factors and
colorectal cancer risk. Cancer Biomark. 14:225–231. 2014.PubMed/NCBI
|
|
11
|
Zutter M, Hockenbery D, Silverman GA and
Korsmeyer SJ: Immunolocalization of the Bcl-2 protein within
hematopoietic neoplasms. Blood. 78:1062–1068. 1991.PubMed/NCBI
|
|
12
|
Pietenpol JA, Papadopoulos N, Markowitz S,
Willson JK, Kinzler KW and Vogelstein B: Paradoxical inhibition of
solid tumor cell growth by bcl2. Cancer Res. 54:3714–3717.
1994.PubMed/NCBI
|
|
13
|
EI-Emshaty HM, Saad EA, Toson EA, Abdel
Malak CA and Gadelhak NA: Apoptosis and cell proliferation:
Correlation with BCL-2 and P53 oncoprotein expression in human
hepatocellular carcinoma. Hepatogastroenterology. 61:1393–1401.
2014.PubMed/NCBI
|
|
14
|
Garewal J, Garewal R and Sircar K:
Expression of Bcl-2 and MIB-1 markers in oral squamous cell
carcinoma (OSCC) - A comparative study. J Clin Diagn Res.
8:QC01–QC04. 2014.PubMed/NCBI
|
|
15
|
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang
P, He X, Wang Q, Huang Y, Jen KY, Labarge MA, et al: CUL4A induces
epithelial-mesenchymal transition and promotes cancer metastasis by
regulating ZEB1 expression. Cancer Res. 74:520–531. 2014.
View Article : Google Scholar :
|
|
16
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: A review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar
|
|
17
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
19
|
Unni KK: Chordoma. Dahlin's Bone Tumors:
General Aspects and Data on 11,087 cases. 5th edition.
Lippincott-Raven; New York, NY: pp. 291–305. 1996
|
|
20
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan L, Wu Q, Xing X, Wei Y and Shao Z:
MicroRNA-145 targets vascular endothelial growth factor and
inhibits invasion and metastasis of osteosarcoma cells. Acta
Biochim Biophys Sin. 44:407–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mao JH, Zhou RP, Peng AF, Liu ZL, Huang
SH, Long XH and Shu Y: microRNA-195 suppresses osteosarcoma cell
invasion and migration in vitro by targeting FASN. Oncol Lett.
4:1125–1129. 2012.PubMed/NCBI
|
|
23
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosar-coma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar
|
|
25
|
Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q
and Ma B: MicroRNA-34a inhibits the proliferation and metastasis of
osteosarcoma cells both in vitro and in vivo. PLoS One.
7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z and Cai H, Lin L, Tang M and Cai H:
Upregulated expression of microRNA-214 is linked to tumor
progression and adverse prognosis in pediatric osteosarcoma.
Pediatr Blood Cancer. 61:206–210. 2014. View Article : Google Scholar
|
|
28
|
Shen L, Chen XD and Zhang YH: MicroRNA-128
promotes proliferation in osteosarcoma cells by downregulating
PTEN. Tumour Biol. 35:2069–2074. 2014. View Article : Google Scholar
|
|
29
|
Jianwei Z, Fan L, Xiancheng L, Enzhong B,
Shuai L and Can L: MicroRNA 181a improves proliferation and
invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol.
34:3331–3337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou Y, Huang Z, Wu S, Zang X, Liu M and
Shi J: miR-33a is up-regulated in chemoresistant osteosarcoma and
promotes osteosarcoma cell resistance to cisplatin by
down-regulating TWIST. J Exp Clin Cancer Res. 33:122014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pan W, Wang H, Jianwei R and Ye Z:
MicroRNA-27a promotes proliferation, migration and invasion by
targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem.
33:402–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh R and Saini N: Downregulation of
BCL2 by miRNAs augments drug-induced apoptosis - a combined
computational and experimental approach. J Cell Sci. 125:1568–1578.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, et al: miR-15 and miR-16 induce apoptosis by
targeting BCL2. Proc Natl Acad Sci USA. 102:13944–13949. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
